Here, we demonstrate that, even though IL-2 activation enhanced degranulation of all NK cell subsets, KIR–ligand-mismatched NK cells still mediated a more potent anti-myeloma response than matched NK cells. Here, KIR3DL1 is linked to plasma cell myeloma.